Blacktrace Holdings Acquires ChemiSens AB Assets
News Feb 20, 2015
Blacktrace Holdings Limited has announced that with effect from 16th January 2015 it has acquired the assets of ChemiSens AB, based in Lund, Sweden. ChemiSens has a 30-year proven track record in the development, manufacture and supply of the highest performance reaction calorimeters.
These sophisticated systems, which will now be supplied and supported via the Syrris brand, perfectly complement the Syrris product range.
Reaction calorimeters are used in a wide range of applications, including carbon capture and sequestration, biological performance, and chemical reaction kinetic and scale-up safety studies.
The combined Syrris and ChemiSens product portfolio - from the straightforward, easy-to-use Atlas Calorimeter to the high performance CPA200 series - allows Syrris to meet customers’ differing needs and applications, whether an introductory or top-end calorimeter is required.
And, with the company’s global presence and the knowledgeable Syrris support team, new and existing customers can be assured of continued worldwide access to professional advice.
Blacktrace is looking forward to working with existing ChemiSens partners, and intends to keep the current structure for the foreseeable future.
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE
Quotient Sciences Launches as the New Global Identity for Quotient ClinicalNews
Quotient is focused on delivering a portfolio of innovative services encompassing formulation development, clinical trial and commercial manufacturing, and clinical pharmacology.READ MORE